Literature DB >> 14582145

Polymorphism screening of PIP5K2A: a candidate gene for chromosome 10p-linked psychiatric disorders.

Pavla Stopkova1, Takuya Saito, Cathy S J Fann, Demitri F Papolos, Jan Vevera, Ivo Paclt, Ilja Zukov, Rafael Stryjer, Rael D Strous, Herbert M Lachman.   

Abstract

Lithium is a potent noncompetitive inhibitor of inositol monophosphatases, enzymes involved in phosphoinositide (PI) and inositol phosphate metabolism. A critical component of the PI pathway is phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P(2)), which is hydrolyzed to second messengers and has a direct role in synaptic vesicle function. Interestingly, a number of genes involved in the synthesis and dephosphorylation of PtdIns(4,5)P(2) are found in regions of the genome previously mapped in bipolar disorder (BD) including 10p12, 21q22, and 22q11, among others. Some of these regions overlap with loci mapped in schizophrenia (SZ). One gene involved in PI metabolism that maps to a region of interest is 10p12-linked PIP5K2A, a member of the phosphatidylinositol 4-phosphate 5-kinase family. Polymorphism screening revealed the existence of an imperfect CT repeat polymorphism located near the exon 9-intron 9 splice donor site. A modest difference was found in the distribution of alleles from this highly polymorphic variant when bipolar and schizophrenic subjects were compared with controls; relatively rare short repeat variants were found more commonly in patients and homozygosity for a common long repeat variant was found more commonly in controls. These data suggest that the imperfect CT repeat in PIP5K2A intron 9 should be further investigated as a possible candidate allele for 10p12-linked psychiatric disorders. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14582145     DOI: 10.1002/ajmg.b.20012

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  15 in total

Review 1.  Wnt signaling: role in Alzheimer disease and schizophrenia.

Authors:  Nibaldo C Inestrosa; Carla Montecinos-Oliva; Marco Fuenzalida
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-18       Impact factor: 4.147

Review 2.  Genetic models of schizophrenia and bipolar disorder: overlapping inheritance or discrete genotypes?

Authors:  Wolfgang Maier; Barbara Höfgen; Astrid Zobel; Marcella Rietschel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-06       Impact factor: 5.270

3.  PIP4K2A regulates intracellular cholesterol transport through modulating PI(4,5)P2 homeostasis.

Authors:  Ao Hu; Xue-Tong Zhao; Heng Tu; Ting Xiao; Ting Fu; Yan Wang; Yong Liu; Xiong-Jie Shi; Jie Luo; Bao-Liang Song
Journal:  J Lipid Res       Date:  2018-01-20       Impact factor: 5.922

4.  Attenuation of phospholipid signaling provides a novel mechanism for the action of valproic acid.

Authors:  Xuehua Xu; Annette Müller-Taubenberger; Kathryn E Adley; Nadine Pawolleck; Vivian W Y Lee; Claudia Wiedemann; Talvinder S Sihra; Markus Maniak; Tian Jin; Robin S B Williams
Journal:  Eukaryot Cell       Date:  2007-04-13

Review 5.  Cellular and molecular interactions of phosphoinositides and peripheral proteins.

Authors:  Robert V Stahelin; Jordan L Scott; Cary T Frick
Journal:  Chem Phys Lipids       Date:  2014-02-17       Impact factor: 3.329

6.  Phosphatidylinositol-4-phosphate 5-kinases and phosphatidylinositol 4,5-bisphosphate synthesis in the brain.

Authors:  Laura A Volpicelli-Daley; Louise Lucast; Liang-Wei Gong; Lijuan Liu; Junko Sasaki; Takehiko Sasaki; Charles S Abrams; Yasunori Kanaho; Pietro De Camilli
Journal:  J Biol Chem       Date:  2010-07-09       Impact factor: 5.157

7.  PIP5K2A-dependent regulation of excitatory amino acid transporter EAAT3.

Authors:  Olga Fedorenko; Cai Tang; Mentor Sopjani; Michael Föller; Eva-Maria Gehring; Nathalie Strutz-Seebohm; Oana N Ureche; Svetlana Ivanova; Arkadij Semke; Florian Lang; Guiscard Seebohm; Undine E Lang
Journal:  Psychopharmacology (Berl)       Date:  2009-07-31       Impact factor: 4.530

8.  A schizophrenia-linked mutation in PIP5K2A fails to activate neuronal M channels.

Authors:  Olga Fedorenko; Nathalie Strutz-Seebohm; Ulrike Henrion; Oana N Ureche; Florian Lang; Guiscard Seebohm; Undine E Lang
Journal:  Psychopharmacology (Berl)       Date:  2008-06-11       Impact factor: 4.530

9.  Association analysis of the PIP4K2A gene on chromosome 10p12 and schizophrenia in the Irish study of high density schizophrenia families (ISHDSF) and the Irish case-control study of schizophrenia (ICCSS).

Authors:  D L Thiselton; B S Maher; B T Webb; T B Bigdeli; F A O'Neill; D Walsh; K S Kendler; B P Riley
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-01-05       Impact factor: 3.568

Review 10.  Mutations in phosphoinositide metabolizing enzymes and human disease.

Authors:  Heather J McCrea; Pietro De Camilli
Journal:  Physiology (Bethesda)       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.